Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05582681 · ClinicalTrials.gov registry record · Phase 4
HCV Test and Treat Utilizing Simplified HCV Patient Education
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT05582681 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 8 participants.
The verdict
NCT05582681, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.
Interventions
- DRUG Glecaprevir and Pibrentasvir
- DIAGNOSTIC_TEST Cepheid POC HCV Viremia (RNA) test
- OTHER HCV education from a health care provider
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-11-11 |
| Est. Completion | 2024-11-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05582681
The ClinicalTrials.gov registry entry for NCT05582681 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Glecaprevir and Pibrentasvir is the first listed.
NCT05582681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05582681 about?
NCT05582681 is a clinical study titled "HCV Test and Treat Utilizing Simplified HCV Patient Education". The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.
What is the current status of trial NCT05582681?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2022-11-11. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT05582681?
The interventions under investigation include: Glecaprevir and Pibrentasvir (DRUG), Cepheid POC HCV Viremia (RNA) test (DIAGNOSTIC_TEST), HCV education from a health care provider (OTHER).
Who is sponsoring clinical trial NCT05582681?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.